Fonte: Applied Cancer Research - Supplement. Nome do evento: São Paulo research conference Cancer Today From Molecular Biology to treatment. Unidade: FM
Assuntos: NEOPLASIAS DOS GENITAIS FEMININOS, RADIOTERAPIA, RESUMOS (EVENTOS), QUIMIOTERAPIA
ABNT
DIZ, M. D. P. E et al. High pathologic response rate of neoadjuvant chemoradiation with gemcitabine in locally advanced vulvar carcinoma. Applied Cancer Research - Supplement. Ribeirão Preto: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 25 set. 2024. , 2005APA
Diz, M. D. P. E., Queiroz, C. J. S., Carvalho, J. P., Petitto, V., Nadalin, W., Folgueira, M. A. A. K., et al. (2005). High pathologic response rate of neoadjuvant chemoradiation with gemcitabine in locally advanced vulvar carcinoma. Applied Cancer Research - Supplement. Ribeirão Preto: Faculdade de Medicina, Universidade de São Paulo.NLM
Diz MDPE, Queiroz CJS, Carvalho JP, Petitto V, Nadalin W, Folgueira MAAK, Almeida GFG, Federico MHH. High pathologic response rate of neoadjuvant chemoradiation with gemcitabine in locally advanced vulvar carcinoma. Applied Cancer Research - Supplement. 2005 ;( 2): 95.[citado 2024 set. 25 ]Vancouver
Diz MDPE, Queiroz CJS, Carvalho JP, Petitto V, Nadalin W, Folgueira MAAK, Almeida GFG, Federico MHH. High pathologic response rate of neoadjuvant chemoradiation with gemcitabine in locally advanced vulvar carcinoma. Applied Cancer Research - Supplement. 2005 ;( 2): 95.[citado 2024 set. 25 ]